BeyondSpring Initiates New Drug Application Rolling Submission for Plinabulin in China for Chemotherapy-Induced Neutropenia

NEXT STORY
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
PREV STORY
Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NICE Issues Draft Guidance on the Use of gammaCore for Cluster Headache

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces First Quarter 2019 Financial Results and Business Update Conference Call on May 30

author_avatar
NASDAQ Market News

OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic Test

ALAMEDA, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer ...

author_avatar
NASDAQ Market News